Substituted benzopyrans as selective estrogen receptor-beta agonists
US7217734B2 · kind B2 · utility
3Cited by
6References
52Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2002 |
| Grant date | May 15, 2007 |
| Priority date | — |
| Expiry date | Nov 7, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D311/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof and processes for the preparation of the same. The compounds of the present invention are useful as Estrogen Receptor β agonists. Such agonists are useful for the treating Estrogen Receptor β mediated diseases such as prostate cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.